Diabetes and thyroid disorders

British Journal of Diabetes and Vascular Disease

Volumn 10, Issue 4, 2010, Pages 172-177

  Brenta, Gabriela ^a  

^a Cesar Milstein Hospital ^*  (Argentina)

Author keywords

Diabetes; Hyperthyroidism; Hypothyroidism; Insulin resistance; Thyroid

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALBUMIN; CARBUTAMIDE; CD3 ANTIGEN; CHLORPROPAMIDE; CREATININE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOSE TRANSPORTER 4; HLA DR3 ANTIGEN; INSULIN; LEVOTHYROXINE; LIOTHYRONINE; METAHEXAMIDE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PHOSPHOGLYCERATE KINASE; THYROID ANTIBODY; THYROTROPIN; TOLBUTAMIDE;

ABDOMINAL SUBCUTANEOUS FAT; AUTOIMMUNE THYROIDITIS; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOLOGY; PREVALENCE; PROTEIN URINE LEVEL; REVIEW; THYROID DISEASE; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

EID: 77957161788     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651410371321     Document Type: Review

References (55)

1. Rohdenburg GL. Thyroid diabetes. Endocrinology 1920;4:63
2. Lenzen S, Bailey CJ. Thyroid hormones, gonadal and adrenocortica steroids and the function of the islets of langerhans. Endocr Rev 1984;5:411-34.
3. Boelaert K, Franklyn JA. Thyroid hormone in health and disease J Endocrinol 2005;187:1-15.
4. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99
5. Canaris GJ, Manowitz NR, Mayor G et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34
6. Surks MI, Hollowell JG. Agespecific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92:4575-82
7. Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism I. Prevalence and clinical relevance. Neth J Med 1995;46:197-204
8. Pearce SH, Merriman TR. Genetics of type 1 diabetes and autoimmune thyroid disease. Endocrinol Metab Clin N Am 2009;38:289-301
9. Perros P, McCrimmon RJ, Shaw G et al. Frequency of thyroid dysfun-ction in diabetic patients: value of annual screening. Diabet Med 1995;12:622-7
10. Kordonouri O, Maguire AM, Knip M et al. Other complications and associated conditions with diabetes in children and adolescents Pediatric Diabetes 2009;10:204-10
11. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2007;92:S1-47
12. Chubb SA, Davis WA, Inman Z. Prevalence and progression of sub-clinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol (Oxf) 2005;62:480-6
13. Gambelunghe G, Forini F, Iaureti S et al. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoanti-bodies. Clin Endocrinol 2000;52:565-73
14. Libman IM, Sun K, Foley TP, Becker DJ. Thyroid autoimmunity in chil-dren with features of both type 1 and type 2 diabetes. Pediatr Diabetes 2008;9:266-71
15. Uzunlulu M, Yorulmaz E, Oǧuz A. Prevalance of subclinical hypo-thyroidism in patients with metabolic syndrome. Endocr J 2007;54 71-6
16. Standards of medical care in diabetes: 2008. Diabetes Care 2008; 31(suppl 1):S12.
17. Kordonouri O, Maguire AM, Knip M et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Other complications and associated condi-tions. Pediatr Diabetes 2007;8:171-6
18. Raboudi N, Arem R, Jones RH et al. Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism. Am J Physiol 1989;256:E159-66
19. Weinstein SP, O'Boyle E, Fisher M, Haber RS. regulation of GlUT2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of the hepatic glucose transport system Endocrinology 1994:135:649-54
20. Viguerie N, Millet I, Avizou S et al. regulation of human adipocyte gene expression by thyroid hormone. J Clin Endocrinol Metab 2002; 87:630-4
21. Clément K, Viguerie N, Diehn M et al. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res 2002;12:281-91
22. Moeller LC, Dumitrescu AM, Walker RL et al. Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab 2005;90:936-43
23. Potenza M, Via MA, Yanagisawa RT et al. Excess thyroid hormone and carbohydrate metabolism. Endocr Pract 2009;15:254-62.
24. Dimitriadis G, Baker B, Marsh H et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985;248:E593-601
25. Muller MJ, Acheson KJ, Jequier E, Burger AG. Effect of thyroid hor-mones on oxidative and nonoxidative glucose metabolism in humans Am J Physiol 1988;255:E146-52
26. Shen DC, Davidson MB, Kuo SW, Sheu WH. Peripheral and hepatic nsulin antagonism in hyperthyroidism. J Clin Endocrinol Metab 1988; 66:565-9.
27. Dimitriadis G, Mitrou P, lambadiari V et al. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J Clin Endocrinol Metab 2008;93:2413-15.
28. Ortega E, Koska J, Pannacciulli N et al. Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthy-roid individuals. Eur J Endocrinol 2008;158:217-21
29. Ximenes HM, lortz S, Jörns A, lenzen S. Triiodothyronine (T3)-mediated toxicity and induction of apoptosis in insulin-producing INS-1 cells. Life Sci 2007;80:2045-50
30. Rochon C, Tauveron I, Dejax C et al. response of glucose disposal to hyperinsulinemia in human hypothyroidism and hyperthyroidism. Clin Sci 2003; 104: 7-15.
31. Handisurya A, Pacini G, Tura A et al. Effects of thyroxine replacement therapy on glucose metabolism in subjects with subclinical and overt hypothyroidism. Clin Endocrinol (Oxf) 2008;69:963-9
32. Dimitriadis G, Mitrou P, Lambadiari V et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006;91:4930-7.
33. Brenta G, Celi FS, Pisarev M et al. Acute thyroid hormone withdrawa in athyreotic patients results in a state of insulin resistance. Thyroid 2009;19:665-9
34. Andreani D, Menzinger G, Fallucca F et al. Insulin levels in thyrotoxico-sis and primary myxoedema: response tointravenous glucose and glu-cagon. Diabetologia 1970;6:1-7
35. Maratou E, Hadjidakis DJ, Kollias A et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009;160:785-90
36. Müller MJ, Paschen U, Seitz HJ. Thyroid hormone regulation of glucose homeostasis in the miniature pig. Endocrinology 1983;112:2025-31
37. 3H labelled glucose. Biochem J 1979;182:565-75
38. McCulloch AJ, Nosadini R, Pernet A et al. Glucose turnover and indices of recycling in thyrotoxicosis and primary thyroid failure. Clin Sci 1983;64:41-7
39. Bakker SJ, ter Maaten JC, Popp-Snijders C. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001;86:1206-11
40. Chubb SA, Davis WA, Davis TM. Interactions among thyroid function, nsulin sensitivity, and serum lipid concentrations: The Fremantle Diabetes Study. J Clin Endocrinol Metab 2005;90:5317-20
41. Chidakel A, Mentuccia D, Celi FS. Peripheral metabolism of thyroid hormone and glucose homeostasis. Thyroid 2005;15:899-903
42. Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238
43. Brown J, Solomon DH. Mechanism of antithyroid effects of a sulfonylurea in the rat. Endocrinology 1958;63:473
44. Cappelli C, Rotondi M, Pirola I et al. TSH-lowering effect of metformin in type2 diabetic patients. Differences between euthyroid, untreated hypothyroid and euthyroid on l-T4 therapy patients. Diabetes Care 2009;32:1589-90
45. Starkey K, Heufelder A, Baker G et al. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazoli-dinedione use? J Clin Endocrinol Metab 2003;88:55-9
46. Venero CV, Thompson PD. Managing statin myopathy. Endocrinol Metab Clin North Am 2009;38:121-36
47. Brenta G, Danzi S, Klein I. Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab 2007; 3:632-64
48. Baxter J, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 2009;8:308-20
49. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131
50. Chen HS, Wu TE, Jap TS et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic pati-ents. Diabet Med 2007;24:1336-44.
51. Yang JK, Liu W, Shi J, li YB. An association between subclinical hypo-thyroidism and sight-threatening diabetic retinopathy In type 2 dia-betic patients. Diabetes Care 2010;33:1018-20
52. Haentjens P, Van Meerhaeghe A, Poppe K et al. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies Eur J Endocrinol 2008;159:329-41
53. Sathyapalan T, Manuchehri AM, Rigby AS, Atkin SL. Subclinical hypo-thyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes. Diabetes Care 2010;33:e37
54. Ochs N, Auer R, Bauer DC et al. Meta-analysis: subclinical thyroid dys-function and the risk for coronary heart disease and mortality. Ann Intern Med 2008;148:832-45
55. Razvi S, Shakoor A, Vanderpump M et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 2008;93 2998-3007